Abstract 917: AZD2014, a dual mTORC1 and mTORC2 inhibitor is differentiated from allosteric inhibitors of mTORC1 in ER+ breast cancerSylvie M. Guichard, Martin Pass, Dan Heathcote et al.|Cancer Research|2012Cited by 17